Epiodyne, Inc. — Form D
Epiodyne, Inc. of SAN FRANCISCO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2017-11-15. The offering totals $10.1M, of which $5.8M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2017-11-15
- Form: D
- Accession: 0001674182-17-000003
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $10.1M
- Amount sold: $5.8M
- Remaining: $4.3M
- Investors: 3
- Date of first sale: 2017-10-02
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-298744
Issuer
- Name: Epiodyne, Inc.
- CIK: 0001674182
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2016
- Address: 953 INDIANA STREET, SAN FRANCISCO, CA, 94107
- Phone: 415-205-4825
Officers, directors & promoters (9)
| Name | Role | Location |
|---|
| Douglas Crawford | Director | San Francisco, CA |
| Douglas Crawford | Executive Officer | San Francisco, CA |
| Douglas Crawford | Related Person | San Francisco, CA |
| Brook Byers | Director | San Francisco, CA |
| Brook Byers | Related Person | San Francisco, CA |
| Brian Shoichet | Director | New York, NY |
| Alex Tkachenko | Director | San Francisco, CA |
| Alex Tkachenko | Executive Officer | San Francisco, CA |
| Alex Tkachenko | Related Person | San Francisco, CA |
Other filings by this issuer (2)
More